Epidemiology of S. pneumoniae serotypes in the Russian Federation | CMAC

Epidemiology of S. pneumoniae serotypes in the Russian Federation

Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(3):200-206

​ Muravyev A.A., Kozlov R.S., Lebedeva N.N.
S. pneumoniae vaccination serotypes epidemiology
Section
Diseases and Pathogens
Type
Journal article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(3):200-206

Abstract

The prevalence of the common serotypes of S. pneumoniae in the Russian Federation was estimated in healthy carriers as well as children and adult patients with invasive and non-invasive pneumococcal infections based on the epidemiological microbiological studies. The majority of circulating serotypes of S. pneumoniae were found to be covered by 10-valent and 13-valent pneumococcal conjugate vaccines and 23-valent polysaccharide pneumococcal vaccine.

Alexander A. Muravyev

Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk, Russia

Roman S. Kozlov

Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk, Russia

Lebedeva N.N.

Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk, Russia

  • 1. WHO position paper on pneumococcal vaccines. Geneva, Switzerland. Published in the Weekly Epidemiological Record on 6 Apr 2012.
  • 2. WHO. Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children. World Health Organization (WHO) Pneumonia Vaccine Trial Investigators group. World Health Organization; 2004. WHO/V&B/01.35.
  • 3. Alter S.J. Pneumococcal infections. Pediatr Rev. 2009;30(5):155-164.
  • 4. Kozlov R.S., Chagarjan A.N., Kozlova L.V., Muravyov A.A. Serological Characteristics and Antimicrobial Susceptibility of Streptococcus pneumoniae Isolated from Children 0-5 Years of Age in Different Regions of Russia. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2011;13(2):177-187. Russian.
  • 5. O'Brien K.L., Nohynek H. Streptococcus pneumoniae. World Health Organization Pneumococcal Vaccine Trials Carraige Working Group. Pediatr Infect Dis J. 2003;22(2):133-140.
  • 6. Introduction of pneumococcal vaccine PCV13, A handbook for district and health facility staff. WHO 2013.
  • 7. Rahman M., Hossain S., Shoma S., et al. Emergence of a unique multiplyantibiotic-resistant Streptococcus pneumoniae serotype 7B clone in Dhaka, Bangladesh. J Clin Microbiol. 2006;44:4625-4627.
  • 8. Baranov A.A., Briko N.I., Namazova-Baranova L.S. Contemporary clinicoepidemiological characteristic of the pneumococcus infections. Lechashhij vrach. 2012;(4). Russian.
  • 9. Lobzin Ju.V., Sidorenko S.V., Harit S.M., et al. Serotypes of Streptococcus pneumoniae causing major pneumococcal infections. Zhurnal infektologii. 2013;5(4):36-42. Russian.
  • 10. Pneumovax 23. Prescribing information. Available at: http://grls. rosminzdrav.ru/Default.aspx. Accessed 28.03.2017. Russian.
  • 11. Order of the Ministry of Health of the Russian Federation, from 21.03.2014 № 125н “On the national calendar of preventive vaccinations and the calendar of preventive vaccinations for epidemic indications”. Russian.
  • 12. Fedoseenko M.V. Perspectives of vaccine prophylaxis of pneumococcal infection: a modern view of the problem. Russkij medicinskij zhurnal. 2009;1:36. Russian.
  • 13. WHO Weekly epidemiological record 2012;87:129-144.
  • 14. Immunoprophylaxis of pneumococcal infections. Briko N.S., ed. I.M. Sechenov First Moscow State Medical University, Moscow 2013. 250 p. Russian.
  • 15. Vaccine prophylaxis of pneumococcal infection. Federal clinical guidelines. Moscow, 2015. 24 p. Russian.
  • 16. Gisselsson-Solén M., Henriksson G., Hermansson A., Melhus A. Risk factors for carriage of AOM pathogens during the first 3 years of life in children with early onset of acute otitis media. Acta Oto-Laryngol. 2014;134(7):684-690.
  • 17. Bayer M., Aslan G., Emekdaş G., Kuyucu N., Kanik A. Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children and multidrug resistance. Mikrobiyoloji Bülteni. 2008;42(2):223-230.
  • 18. Baranov A.A., Namazova-Baranova L.S., Majanskij N.A. Role of Streptococcus pneumoniae in the Structure of Bacterial Infections in the Children Hospitalized to Inpatient Hospitals in Moscow in 2011-2012. Pediatricheskaja farmakologija. 2013;10(5):6-12. Russian.
  • 19. Feldblum I.V., Semerikov V.V., Golodnova S.O., et al Results of serotyping of Str. pneumoniae strains circulating in perm. Zdorov'e sem'i – 21 vek. 2013;2(15):194-203. Russian.
  • 20. WHO: 2012. Health statistic Report. Available at: http://www.who.int/gho/publications/world_health_statistics/2012/en.
  • 21. Kozlov R.S. Pneumococci: lessons of the past – look in the future. Smolensk: IACMAC, 2010. 128 p. Russian.
  • 22. Kozlov R.S., Krechikova O.I., Muravyov A.A., et al. Incidence of CommunityAcquired Pneumonia and Acute Otitis Media in Children 0-5 Years in Russia and Role of S. pneumonia or H. influenzae in the Etiology of the Diseases. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2013;15(4):246-260. Russian.
  • 23. Ortqvist A., Hedlund J., Kalin M. Streptococcus pneumoniae: Epidemiology, Risk Factors, and Clinical Features. Semin Respir Crit Care Med. 2005;26(6):563-574.
  • 24. Russel F., Sanderson C., Temple B., Mulholland K. Global review of the distribution of pneumococcal disease by age and region. SAGE meeting, 8-10 November 2011.
  • 25. Sidorenko S.V. Pneumococcal infection – in the center of attention again. Voprosy sovremennoj pediatrii. 2009;8(3):82-87. Russian.
  • 26. Samatova E.V., Druj A.E., Caur G.A., Boronina L.G. Serotyping of Streptococcus pneumoniae strains, isolated from children in Ural region with the use of multiplex PCR. Jepidemiologija i infekcionnye bolezni. 2012;5:26-30. Russian.
  • 27. Vengerov Ju.Ja., Nagibina M. V., Mihalinova E.P., et al. Pneumococcal meningitis. Problem of high rate of mortality. Lechashhij vrach. 2013;(5). Russian.
  • 28. Koroleva I.S., Beloshickij G.V., Mironov K.O. Serotype characteristic of pneumococci isolated from patients with pneumococcal meningitis. Voprosy sovremennoj pediatrii. 2012;11(4):122-127. Russian.
  • 29. Baranov A.A. Streptococci and pneumococci. Rostov-on-Don: Feniks, 2013. 301 p. Russian.
  • 30. Koroleva I.S., Harit C.M., Ruleva A.A., Perova A.L., Sidorenko S.V. Pneumococcal infection in Russia: epidemiological situation. Pediatricheskaja farmakologija. 2010;7(4):12-18. Russian.
  • 31. McEllistrem M.C., Adams J., Mason E.O., Wald E.R. Epidemiology of Acute Otitis Media Caused by Streptococcus pneumoniae Before and After Licensure of the 7-Valent Pneumococcal Protein Conjugate Vaccine. J Infect Dis. 2003;188(11):1679-1684.
  • 32. Emergence of Antimicrobial-Resistant Serotype 19A Streptococcus pneumoniae – Massachusetts, 2001-2006. MMWR Morb Mortal Wkly Rep. 2007;56(41):1077-1180.
  • 33. Martí S.G., Colantonio L., Bardach A., et al. A cost-effectiveness analysis of a 10-valent pneumococcal conjugate vaccine in children in six Latin American countries. Cost Eff Resour Alloc. 2013;11(1):21.
  • 34. Grabenstein J., Weber D.J. Pneumococcal serotype diversity among adults in various countries influence by pediatric pneumococcal vaccination uptake. Clin Infect Dis. 2014;58:854-864.
  • 35. Moreno J., Hernández E., Sanabria O., Castañeda E. Detection and Serotyping of Streptococcus pneumoniae from Nasopharyngeal Samples by PCRBased Multiplex Assay. J Clin Microbiol. 2005;43(12):6152-6154.
  • 36. Muravyov A.A., Chagarjan A.N., Bratus E.V., et al. Serological Characteristics and Antimicrobial Susceptibility of Streptococcus pneumoniae Isolated from Children Under 5 Years and Patients >65 Years in Belarus and Ukraine. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2013;15(2):147-158. Russian.
  • 37. Gupta A., Khaw F.M., Stokle E.L., et al. Outbreak of Streptococcus pneumoniae serotype 1 pneumonia in a United Kingdom school. BMJ 2008;337:a2964.
  • 38. Yoshioka C.R., Martinez M.B., Brandileone M.C., et al. Analysis of invasive pneumonia-causing strains of Streptococcus pneumoniae: serotypes and antimicrobial susceptibility. J Pediatr (Rio J). 2011;87(1):70-75.
  • 39. Falkenhorst G., Remschmidt C., Harder T., et al. Background paper to the updated pneumococcal vaccination recommendation for older adults in Germany. Bundesgesundheitsbl 2016;59:1623-1657.
  • 40. Inostroza J., Vinet A.M., Retamal G., et al. Influence of Patient Age on Streptococcus pneumoniae Serotypes Causing Invasive Disease. Clin Diagn Lab Immunol. 2001;8(3):556-559.
  • 41. Andrews N.J., Waight P.A., Burbidge P., et al. Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. Lancet Infect Dis. 2014;14:839-846.
  • 42. Direct and indirect effects of routine vaccination of children with 7 valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease United States, 1998-2003. MMWR Morb Mortal Wkly Rep. 2005;54(36):893-897.
  • 43. Centers for Disease Control and Prevention (CDC). Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morbidity and Mortality Weekly Report. 2015;64(34):944-947. (Erratum Notice: CDC. MMWR Morb Mortal Wkly Rep. 2015;64(42):1204.).
Views
0 Abstract
0 PDF
0 Crossref citations
Shared